Cargando…

Chirped guided-mode resonance biosensor

Advanced biomedical diagnostic technologies fulfill an important role in improving health and well-being in society. A large number of excellent technologies have already been introduced and have given rise to the “lab-on-a-chip” paradigm. Most of these technologies, however, require additional inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Triggs, Graham J., Wang, Yue, Reardon, Christopher P., Fischer, Matthias, Evans, Gareth J. O., Krauss, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Optical Society of America 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513287/
https://www.ncbi.nlm.nih.gov/pubmed/31149627
http://dx.doi.org/10.1364/OPTICA.4.000229
Descripción
Sumario:Advanced biomedical diagnostic technologies fulfill an important role in improving health and well-being in society. A large number of excellent technologies have already been introduced and have given rise to the “lab-on-a-chip” paradigm. Most of these technologies, however, require additional instrumentation for interfacing and readout, so they are often confined to the laboratory and are not suitable for use in the field or in wider clinical practice. Other technologies require a light coupling element, such as a grating coupler or a fiber coupler, which complicates packaging. Here, we introduce a novel biosensor based on a chirped guided-mode resonant grating. The chirped grating combines the sensing function with the readout function by translating spectral information into spatial information that is easily read out with a simple CMOS camera. We demonstrate a refractive index sensitivity of 137 nm/RIU and an extrapolated limit of detection of 267 pM for the specific binding of an immunoglobulin G antibody. The chirped guided-mode resonance approach introduces a new degree of freedom for sensing biomedical information that combines high sensitivity with autonomous operation. We estimate that the cost of components is U.S. $10 or less when mass manufactured, so the technology has the potential to truly transform point-of-care applications.